206650.KQ
EuBiologics Co., Ltd.
KOE · Healthcare · Drug Manufacturers - Specialty & Generic · KR
KRW 8,690.00
−2.80%Year over year
Reported trailing growth
- Revenue
- -17.8%
- EBITDA
- -3.8%
- EBIT
- -29.9%
- EPS
- -39.5%
- Free cash flow
- -69.4%
- Operating cash flow
- -64.1%
Forward estimates
Based on analyst estimates
- Revenue
- —
- EBITDA
- —
- EPS
- —
Three-year CAGR
- Revenue
- +39.1%
- EBITDA
- +136.0%
- EBIT
- +180.7%
- Net income
- +117.3%
- EPS
- +115.2%
- Free cash flow
- +38.8%
Reported trailing growth, forward expectations and three-year compound growth rates · Data as of Jun 1, 2026